GO
Loading...

Enter multiple symbols separated by commas

Search results for "ARIA"

REFINE RESULTS

SEARCH RESULTS

About 5 results. Sort By: Date | Relevance
UPDATE 1-Ariad Pharma CEO Berger to retire in deal with top investor

April 29- Ariad Pharmaceuticals Inc said Chief Executive Harvey Berger would retire as part of a deal to settle its proxy battle with largest shareholder Sarissa Capital Management. Ariad's shares were up 4 percent at $9.22 in premarket trading. Sarissa, an activist fund run by investor Carl Icahn's former healthcare lieutenant, Alex Denner, holds a 6.85...
Source: Reuters
Ariad CEO to retire in deal with activist Sarissa

Ariad Pharmaceuticals CEO Harvey Berger will retire this year in a settlement with hedge fund Sarissa Capital, capping months of agitation.
Source: CNBC.com | By: Meg Tirrell
Ariad CEO Berger to step down in settlement deal with Sarissa

April 29- Sarissa Capital Management LP said Ariad Pharmaceuticals Inc's Harvey Berger would retire as CEO as part of a deal to settle the hedge funds's proxy battle with the drugmaker.
Source: Reuters
CNBC update: Jodi Arias sentencing  

A judge sentenced Jodi Arias to life without parole; United States Secretary of State John Kerry objects to Russia's missile sale to Iran; and Italy coast guard rescued thousands of migrants from sea, reports CNBC's Sue Herera.
Source: CNBC.com
Trading Nation, April 13, 2015  

Tod Gordon TradingAnalysis.com and David Seaburg of Cowen, discuss their best trading ideas and what stocks they'll be watching.
Source: CNBC.com